Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
keynote 189 | 1.19 | 0.9 | 5005 | 46 | 11 |
keynote | 0.62 | 0.8 | 1186 | 88 | 7 |
189 | 0.21 | 0.8 | 6946 | 97 | 3 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
keynote 189 | 1.27 | 0.9 | 8250 | 99 |
keynote 189 trial | 1.99 | 0.2 | 7330 | 14 |
keynote 189 5 year update | 1.26 | 0.7 | 7447 | 97 |
keynote 189 nejm | 1.96 | 0.5 | 4665 | 12 |
keynote 189 update | 1.81 | 0.2 | 2924 | 78 |
keynote 189 os | 1.94 | 0.2 | 1700 | 85 |
keynote 189 pfs | 1.46 | 0.8 | 7832 | 41 |
keynote 189 study | 1.71 | 0.2 | 8439 | 14 |
keynote 189 protocol | 0.4 | 0.5 | 785 | 58 |
keynote 189 overall survival | 1.37 | 0.8 | 945 | 86 |
keynote 189 orr | 0.38 | 0.1 | 5383 | 52 |
keynote 189 study design | 1.09 | 0.4 | 8306 | 42 |
keynote 189 5 year | 0.96 | 0.5 | 5653 | 12 |
keynote 189 updated analysis | 0.94 | 0.6 | 6421 | 86 |
keynote 189 design | 0.75 | 0.4 | 2739 | 84 |
keynote 189 jco outcome | 0.88 | 0.4 | 5280 | 12 |
updated keynote 189 | 0.94 | 0.3 | 8323 | 90 |
pembrolizumab keynote 189 | 0.43 | 0.9 | 112 | 17 |